• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

溃疡性结肠炎叙事全球调查结果:与溃疡性结肠炎患者共同生活的影响——患者和医生的观点。

Ulcerative Colitis Narrative Global Survey Findings: The Impact of Living With Ulcerative Colitis-Patients' and Physicians' View.

机构信息

Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Hyogo College of Medicine, Hyogo, Japan.

出版信息

Inflamm Bowel Dis. 2021 Oct 20;27(11):1747-1755. doi: 10.1093/ibd/izab016.

DOI:10.1093/ibd/izab016
PMID:33529314
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8528151/
Abstract

BACKGROUND

The Ulcerative Colitis (UC) Narrative is a global patient and physician survey aimed at identifying the impact of UC and comparing and contrasting perceptions of UC burden and management approaches.

METHODS

Surveys of patients with UC (self-reported diagnosis; n = 2100) and physicians (n = 1254) were completed across 10 countries by The Harris Poll between August 2017 and February 2018. Questionnaires covered multiple aspects of UC, including diagnosis, treatment, and impact on patient quality of life, in addition to standard demographic information. Descriptive statistics are reported.

RESULTS

The majority of patients (82%) had moderate to severe UC (based on medication history; those who had only ever taken 5-aminosalicylates were excluded); 67% described their UC as controlled with few to no symptoms. On average, patients experienced 4.3 flares (standard deviation, 7.4) in the past year. Diagnostic delay was on average 2.0 years (standard deviation, 5.4); 42% of patients waited ≥1 year. Most patients (65%) felt that UC controlled their life rather than them controlling their disease. Because of the fear of repercussions, many patients had not disclosed their UC to their employer. Discussion of the emotional impact of UC during routine appointments was less of a priority for physicians, compared with patients.

CONCLUSIONS

The data from this global survey highlight that patients with UC experience diagnostic delay, poor disease control, and adverse impact on their quality of life. Patients report UC to be a mentally exhausting condition; however, emotional and mental health issues are infrequently discussed at routine appointments.

摘要

背景

溃疡性结肠炎(UC)叙事是一项全球性的患者和医生调查,旨在确定 UC 的影响,并比较和对比 UC 负担和管理方法的认知。

方法

2017 年 8 月至 2018 年 2 月期间,The Harris Poll 在 10 个国家/地区对溃疡性结肠炎患者(自我报告诊断;n=2100)和医生(n=1254)进行了调查。调查问卷涵盖了 UC 的多个方面,包括诊断、治疗以及对患者生活质量的影响,此外还包括标准的人口统计学信息。报告了描述性统计数据。

结果

大多数患者(82%)患有中重度 UC(基于用药史;排除仅服用过 5-氨基水杨酸的患者);67%的患者自述 UC 得到控制,症状很少或没有。平均而言,患者在过去一年中经历了 4.3 次发作(标准差,7.4)。平均诊断延迟 2.0 年(标准差,5.4);42%的患者等待了≥1 年。大多数患者(65%)认为 UC 控制了他们的生活,而不是他们控制了疾病。由于担心后果,许多患者没有向雇主透露他们的 UC。与患者相比,医生在常规就诊时较少讨论 UC 的情绪影响。

结论

这项全球调查的数据突显了 UC 患者存在诊断延迟、疾病控制不佳和生活质量受到不良影响的问题。患者报告 UC 是一种精神疲惫的疾病;然而,情绪和心理健康问题在常规就诊时很少被讨论。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/507d/8528151/30077241f070/izab016_fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/507d/8528151/b405136e34b7/izab016_ifig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/507d/8528151/f561cc2cde02/izab016_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/507d/8528151/26ff22df7371/izab016_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/507d/8528151/95759978b554/izab016_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/507d/8528151/30077241f070/izab016_fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/507d/8528151/b405136e34b7/izab016_ifig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/507d/8528151/f561cc2cde02/izab016_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/507d/8528151/26ff22df7371/izab016_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/507d/8528151/95759978b554/izab016_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/507d/8528151/30077241f070/izab016_fig4.jpg

相似文献

1
Ulcerative Colitis Narrative Global Survey Findings: The Impact of Living With Ulcerative Colitis-Patients' and Physicians' View.溃疡性结肠炎叙事全球调查结果:与溃疡性结肠炎患者共同生活的影响——患者和医生的观点。
Inflamm Bowel Dis. 2021 Oct 20;27(11):1747-1755. doi: 10.1093/ibd/izab016.
2
Ulcerative Colitis Narrative findings: Australian survey data comparing patient and physician disease management views.溃疡性结肠炎叙述性研究结果:澳大利亚调查数据比较患者与医生对疾病管理的看法。
JGH Open. 2021 Aug 14;5(9):1033-1040. doi: 10.1002/jgh3.12627. eCollection 2021 Sep.
3
Ulcerative Colitis Narrative Global Survey Findings: Communication Gaps and Agreements Between Patients and Physicians.溃疡性结肠炎叙事全球调查结果:患者与医生之间的沟通差距和共识。
Inflamm Bowel Dis. 2021 Jun 15;27(7):1096-1106. doi: 10.1093/ibd/izaa257.
4
The ulcerative colitis narrative Greece survey: patients' and physicians' perspective on quality of life and disease management.希腊溃疡性结肠炎叙述性调查:患者和医生对生活质量及疾病管理的看法
Ann Gastroenterol. 2022 May-Jun;35(3):267-274. doi: 10.20524/aog.2022.0708. Epub 2022 Mar 25.
5
Impact of ulcerative colitis on patients' lives: results of the Finnish extension of a global ulcerative colitis narrative survey.溃疡性结肠炎对患者生活的影响:全球溃疡性结肠炎叙述性调查芬兰扩展版的结果
Scand J Gastroenterol. 2019 Jul;54(7):869-875. doi: 10.1080/00365521.2019.1635637. Epub 2019 Jul 7.
6
Notable gaps between patients' and physicians' perspectives on communication and disease management in Japan: multifaceted analyses of the global Ulcerative Colitis Narrative Survey for further optimal care.日本患者与医生在沟通及疾病管理方面观点的显著差距:对全球溃疡性结肠炎叙事性调查的多方面分析以实现更优化的护理
Therap Adv Gastroenterol. 2022 Jun 14;15:17562848221095372. doi: 10.1177/17562848221095372. eCollection 2022.
7
The Impact of the COVID-19 Pandemic on Patients with Ulcerative Colitis: Results from a Global Ulcerative Colitis Narrative Patient Survey.2019年冠状病毒病大流行对溃疡性结肠炎患者的影响:一项全球溃疡性结肠炎患者叙述性调查结果
Adv Ther. 2024 Feb;41(2):598-617. doi: 10.1007/s12325-023-02673-0. Epub 2023 Dec 4.
8
National differences in ulcerative colitis experience and management among patients from five European countries and Canada: an online survey.五个欧洲国家和加拿大的溃疡性结肠炎患者的患病经历和治疗管理的国家差异:一项在线调查。
J Crohns Colitis. 2013 Jul;7(6):497-509. doi: 10.1016/j.crohns.2012.07.027. Epub 2012 Aug 23.
9
Health Care Disparities, Social Determinants of Health, and Emotional Impacts in Patients with Ulcerative Colitis: Results from a Global Ulcerative Colitis Narrative Patient Survey.溃疡性结肠炎患者的医疗保健差异、健康的社会决定因素和情绪影响:来自全球溃疡性结肠炎叙事患者调查的结果。
Inflamm Bowel Dis. 2023 Nov 2;29(11):1681-1692. doi: 10.1093/ibd/izad102.
10
Perception gaps between patients with ulcerative colitis and healthcare professionals: an online survey.溃疡性结肠炎患者与医疗保健专业人员之间的认知差距:一项在线调查。
BMC Gastroenterol. 2012 Aug 15;12:108. doi: 10.1186/1471-230X-12-108.

引用本文的文献

1
Faecalibacterium prausnitzii enhances intestinal IgA response by host-microbe derived inecalcitol in colitis.普拉梭菌通过宿主-微生物衍生的骨化二醇增强结肠炎中的肠道IgA反应。
BMC Med. 2025 Jul 15;23(1):425. doi: 10.1186/s12916-025-04260-2.
2
Bowel urgency in ulcerative colitis: effect of baseline urgency and change in urgency in response to mirikizumab.溃疡性结肠炎中的肠道急迫感:基线急迫感及对mirikizumab反应中急迫感变化的影响
J Patient Rep Outcomes. 2025 Jul 1;9(1):75. doi: 10.1186/s41687-025-00906-0.
3
Achievement of long-term treatment goals in upadacitinib-treated patients with moderately to severely active ulcerative colitis: a post hoc analysis of phase 3 trial data.

本文引用的文献

1
Ulcerative Colitis Narrative Global Survey Findings: Communication Gaps and Agreements Between Patients and Physicians.溃疡性结肠炎叙事全球调查结果:患者与医生之间的沟通差距和共识。
Inflamm Bowel Dis. 2021 Jun 15;27(7):1096-1106. doi: 10.1093/ibd/izaa257.
2
THE ONSET OF CLINICAL MANIFESTATIONS IN INFLAMMATORY BOWEL DISEASE PATIENTS.炎症性肠病患者临床症状的发作
Arq Gastroenterol. 2018 Jul-Sep;55(3):290-295. doi: 10.1590/S0004-2803.201800000-73.
3
Optimizing the multidimensional aspects of the patient-physician relationship in the management of inflammatory bowel disease.
乌帕替尼治疗中度至重度活动性溃疡性结肠炎患者长期治疗目标的达成:一项3期试验数据的事后分析
J Crohns Colitis. 2025 Jul 3;19(7). doi: 10.1093/ecco-jcc/jjaf095.
4
Obefazimod in patients with moderate-to-severely active ulcerative colitis: efficacy and safety analysis from the 96-week open-label maintenance phase 2b study.奥贝法莫德治疗中度至重度活动性溃疡性结肠炎患者:来自96周开放标签维持2b期研究的疗效和安全性分析
J Crohns Colitis. 2025 May 8;19(5). doi: 10.1093/ecco-jcc/jjaf074.
5
Questionnaire Survey of Japanese Patients With Inflammatory Bowel Disease and Physicians on Shared Decision-Making in Advanced Therapy: A Web-Based PAIR Survey.日本炎症性肠病患者与医生关于晚期治疗共同决策的问卷调查:一项基于网络的配对调查
Crohns Colitis 360. 2025 Apr 9;7(2):otaf014. doi: 10.1093/crocol/otaf014. eCollection 2025 Apr.
6
Psychological interventions for treatment of inflammatory bowel disease.用于治疗炎症性肠病的心理干预措施。
Cochrane Database Syst Rev. 2025 Apr 17;4(4):CD006913. doi: 10.1002/14651858.CD006913.pub3.
7
Mapping the Ulcerative Colitis Patient Journey in Saudi Arabia from Healthcare Professionals' Perspective: A Cross-Sectional Non-Interventional Study.从医疗专业人员视角描绘沙特阿拉伯溃疡性结肠炎患者的就医历程:一项横断面非干预性研究
J Clin Med. 2025 Feb 27;14(5):1621. doi: 10.3390/jcm14051621.
8
Three-Year Efficacy and Safety of Mirikizumab Following 152 Weeks of Continuous Treatment for Ulcerative Colitis: Results From the LUCENT-3 Open-Label Extension Study.溃疡性结肠炎连续治疗152周后mirikizumab的三年疗效和安全性:LUCENT-3开放标签扩展研究结果
Inflamm Bowel Dis. 2024 Oct 25. doi: 10.1093/ibd/izae253.
9
Health-Related Quality of Life Outcomes With Etrasimod Treatment in Patients With Ulcerative Colitis: A Post Hoc Analysis of Data From ELEVATE UC 52 and ELEVATE UC 12.乌司奴单抗治疗溃疡性结肠炎患者的健康相关生活质量结局:来自ELEVATE UC 52和ELEVATE UC 12数据的事后分析
Inflamm Bowel Dis. 2024 Sep 26. doi: 10.1093/ibd/izae229.
10
Patient experiences in ulcerative colitis: conceptual model and review of patient-reported outcome measures.溃疡性结肠炎患者的经历:概念模型及患者报告结局指标综述
Qual Life Res. 2024 May;33(5):1373-1387. doi: 10.1007/s11136-024-03612-4. Epub 2024 Mar 5.
优化炎症性肠病管理中患者与医生关系的多维度方面。
Intest Res. 2018 Oct;16(4):509-521. doi: 10.5217/ir.2018.00074. Epub 2018 Oct 25.
4
Patients' perceptions of the impact of ulcerative colitis on social and professional life: results from the UC-LIFE survey of outpatient clinics in Spain.患者对溃疡性结肠炎对社交和职业生活影响的认知:西班牙门诊诊所UC-LIFE调查结果
Patient Prefer Adherence. 2018 Sep 18;12:1815-1823. doi: 10.2147/PPA.S175026. eCollection 2018.
5
Diagnostic delay in inflammatory bowel disease increases the risk of intestinal surgery.炎症性肠病的诊断延迟会增加肠道手术的风险。
World J Gastroenterol. 2017 Sep 21;23(35):6474-6481. doi: 10.3748/wjg.v23.i35.6474.
6
Adapting to ulcerative colitis to try to live a 'normal' life: a qualitative study of patients' experiences in the Midlands region of England.适应溃疡性结肠炎,努力过“正常”生活:英格兰中部地区患者体验的定性研究。
BMJ Open. 2017 Aug 21;7(8):e017544. doi: 10.1136/bmjopen-2017-017544.
7
Communication Between Physicians and Patients with Ulcerative Colitis: Reflections and Insights from a Qualitative Study of In-Office Patient-Physician Visits.溃疡性结肠炎患者与医生之间的沟通:对门诊医患就诊情况定性研究的思考与见解
Inflamm Bowel Dis. 2017 Apr;23(4):494-501. doi: 10.1097/MIB.0000000000001048.
8
Ulcerative colitis.溃疡性结肠炎。
Lancet. 2017 Apr 29;389(10080):1756-1770. doi: 10.1016/S0140-6736(16)32126-2. Epub 2016 Dec 1.
9
Perceived Emotional and Psychological Impact of Ulcerative Colitis on Outpatients in Spain: UC-LIFE Survey.西班牙溃疡性结肠炎对门诊患者的感知情绪和心理影响:UC-LIFE调查
Dig Dis Sci. 2017 Jan;62(1):207-216. doi: 10.1007/s10620-016-4363-3. Epub 2016 Nov 5.
10
Impact of inflammatory bowel disease on Japanese patients' quality of life: results of a patient questionnaire survey.炎症性肠病对日本患者生活质量的影响:一项患者问卷调查结果
J Gastroenterol. 2017 May;52(5):555-567. doi: 10.1007/s00535-016-1241-x. Epub 2016 Jul 28.